4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC
Reg. FD
Reports First Quarter Financial Results
Financial Results, Press Release
Ajay Dhankhar Appointed to Bioventus Inc. Board of Directors
Reports Third Quarter Financial Results
Reports Second Quarter Financial Results
News, Material Contracts
Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Correspondence
Submission Upload
SEC Staff Correspondence